Metagenomics Market to Gain Good Growth on the Back of COVID-19 Drugs and Vaccines Development: TMR

ALBANY, N.Y., Sept. 21, 2020 /PRNewswire/ -- Metagenomics is the study of microbes in their natural living environment and involves complex microbial communities in which they usually exist. Swift advancements in genomic technologies have widened the growth prospects of the metagenomics market greatly and are also expected to garner growth between 2020 and 2030 on the same grounds.

Considering the aforementioned factors, the global metagenomics market is expected to record a healthy CAGR during the forecast period of 2020-2030. The global metagenomics market was valued at US$ 1.3 bn in 2019.

Metagenomics analysis platforms are riding on the waves of immense popularity among the researchers for conducting metagenomics sequencing to find the closest genome to SARS-CoV-2. In addition, metagenomics also plays a vital role in curing neuroinfectious diseases. This aspect may bring tremendous growth opportunities.

Request for Analysis of COVID-19 Impact on Metagenomics Market – https://www.transparencymarketresearch.com/covid19.php

Metagenomics Market: Analysts Opinion

The analysts at Transparency Market Research (TMR) highlight the growing influence of integrated bioinformatics tools in inviting expansive growth for the metagenomics market. Advanced metagenomics analysis platforms are transforming the concept of automated placement of COVID-19 with the closest known viruses into reality according to the TMR analysts.

Microbial ecologists are using shotgun metagenomics greatly to assess microbial diversity in soil, posing a good growth opportunity for the metagenomics market according to analysts. However, limited sequence assembly from intensely complex samples proves to be an obstacle for the microbial ecologists. The analysts advise the players to increase awareness about flow cytometry-enabled mini- metagenomics to assist microbial ecologists to capture expanded microbial diversity from forest soil.

Request Brochure of Metagenomics Market Report - https://www.transparencymarketresearch.com/brochure.php

Metagenomics Market: Prominent Findings

• Drug discovery revenue is prognosticated to reach from ~22 percent in 2019 to ~26 percent by the end of 2030 in the metagenomics market
• The instruments segment is extrapolated to record a notable share of the metagenomics market
• In terms of technology, the 16S sequencing segment acquired a significant share in 2019
• The clinical diagnostics segment held a major share of the global metagenomics market in regards to application in 2019
• North America emerged as a champion in terms of regional growth contribution in 2019
• Europe is expected to expand at an impressive CAGR between 2020 and 2030

Explore 198 pages of superlative research, current market scenario, and extensive geographical projections. Gain insights into the Metagenomics Market (Product Type: Instruments, Kits & Reagents, and Software & Services; Technology: 16S Sequencing, Whole Genome Sequencing, Shotgun Sequencing, and Others; and Application: Ecology & Environment, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Beverages, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 at https://www.transparencymarketresearch.com/report-toc/52695

Metagenomics Market: Growth Propellers

State-of-the-art tools such as the Integrated Microbial Genome are expected to accelerate the workflow of metagenomics. This aspect may serve as a prominent growth generator for the metagenomics market.

• Magnifying research and development activities are bringing immense growth prospects for the metagenomics market
• Advancements in terms of sequencer instruments development and the presence of data analysis software are serving as growth multipliers for the metagenomics market
• Soaring demand for safe food production and preservation is giving a Midas touch to the growth of the metagenomics market

Purchase the Metagenomics Market Report - https://www.transparencymarketresearch.com/checkout.php

Metagenomics Market: COVID-19 Impact

Metagenomics has been playing a crucial role in the development of an efficient COVID-19 vaccine or drug. Clinical metagenomics is changing the diagnostic landscape. The ability to monitor the virus in real-time and assistance in matching the COVID-19 genome may bring promising insights for developing a good COVID-19 vaccine. Therefore, the metagenomics analysis platforms may observe great demand during the pandemic.

Metagenomics Market: Key Players

Some well-entrenched players in the metagenomics market are TAKARA BIO INC., Promega Corporation, Danaher QIAGEN, Oxford Gene Technology Inc., ELITechGroup, and Thermo Fisher Scientific Inc.

Browse More Press Release - https://www.transparencymarketresearch.com/press-releases.htm

Global Metagenomics Market: Segmentation

By Product Type

• Instruments
• Kits & Reagents
• Software & Services
• By Technology
• 16S Sequencing
• Whole Genome Sequencing
• Shotgun Sequencing
• Others

By Application

• Ecology & Environment
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Food & Beverages
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Drug Delivery Systems Market: The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. Increase in demand for self-administration and home health care devices are likely to fuel expansion of the global drug delivery systems market from 2017 to 2025

Alpha 1 Antitrypsin Deficiency Treatment Market: The global Alpha 1 Antitrypsin Deficiency Treatment market was valued at US$ 1.4 Bn in 2018 and is anticipated to grow at a CAGR of 10.1% from 2019 to 2027, rising incidence & prevalence of respiratory diseases and growing awareness for alpha 1 antitrypsin (AAT) deficiency are projected to drive the market

Liposome Drug Delivery Market: The global liposome drug delivery market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a considerable CAGR from 2019 to 2027. Liposomes are considered the novel drug delivery systems, which are defined as vesicular structures consisting of bilayers formed spontaneously when phospholipids are dispersed in water. Liposomes aid in delivering drugs by the process of diffusion rather than by direct cell fusion

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/metagenomics-market.htm
Website: https://www.transparencymarketresearch.com/

SOURCE Transparency Market Research